Pfizer, represented by Luzzatto, requested to amend the period of Patent Term Extension granted for IL 139110, under Section 170 of the Law which authorizes the Commissioner to adjust the Patent Register. The original patent was due to lapse on… Read More ›
Opposition to IL 187923 to Xeda International – keeping fruit and vegetables free from penicillium mould
Phosphite ions have been long used to prevent infection of citrus fruits with penicillium mold. The treatment is less than successful for treating fruit that is already infected and typically additional chemicals have been used, but these are carcinogenic and… Read More ›
Appeal to Supreme Court, Should a Judge who points out the Weakness of a Case at Pretrial, Recuse Herself for Having Preconceptions?
Yehoshua Fishler is suing G.A. Ehrlich LTD (Ehrlich & Fenster) in the Tel Aviv – Jaffa District Court. He requested that Judge M Amit Anisman withdraw from the case. The case concerns allegations and counter allegations of breach of contract… Read More ›
Fischler vs. Ehrlich – Should the Judge Recuse Herself for Expressing a Negative Opinion on Plaintiff’s Likelihood of Prevailing in Pre-trial Hearing?
This is an interim ruling concerning a financial dispute between Joshua Fischler and G.A. Ehrlich (1995) ltd. In response to a preliminary assessment that the case was weak, and plaintiff (Fischler) should post a bond to cover Ehrlich’s costs, should… Read More ›
District Court Judge Requires Plaintiff Suing Patent Attorney for Failing to Pay Issue Fees on his Behalf, to Post Bond of 50,000 NIS to Cover Defendant’s Costs
Joshua Fischler has sued G.A. Ehrlich ltd (Ehrlich & Fenster Patent Attorneys – henceforth Ehrlich) for failing to pay the issue fee of an Australian Patent, thereby allegedly causing them damage of 21,000,000 Shekels. For the sake of the court… Read More ›
This case relates to a request to revive an abandoned Application, where the Agent of Record was under the impression that he was instructed to abandon, and thus failed to respond to the office action and to the Notice of… Read More ›
Opposition to IL 190827 to Pfizer – A request to delete paragraphs from Expert Opinion as Widening Front of Attack
In evidence submissions, parties can support contentions made in statements of case, but are not allowed to widen their position by introducing new matter. When evidence relating to allegedly new issues is submitted by an Opposer, the Applicant can be… Read More ›
Patent Application IL 201320 to Pfizer is titled “CRYSTALLINE FORMS OF 6-[2- (METHYLCARBAMOYL) PHENYLSULFANYL]-3- E -[2- (PYRIDIN2- YL] ETHENYL] INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS”. On allowance, it published for Opposition purposes, and Unipharm submitted… Read More ›
The Manufacturers Association of Israel opposed an ex-partes decision to allow a patent term extension for Dexlansoprazole, and New Commissioner Ofer Alon has disallowed the extension accepted by his predecessor. Background Dexlansoprazole is used for treating gastro-reflux and for treating… Read More ›
Israel Patent Application No. 176831 to Novartis is titled “COMPRESSED PHARMACEUTICAL TABLETS OR DIRECT COMPRESSION PHARMACEUTICAL TABLETS COMPRISING DPP-IV INHIBITOR CONTAINING PARTICLES AND PROCESSES FOR THEIR PREPARATION”. It is the national phase entry of PCT/EP2005/000400. On allowance, Unipharm filed an… Read More ›